GPR161 and neoplasm: Of note, analysis of somatic mutations in known and putative MB driver genes revealed biallelic inactivation of GPR161 as the sole shared event across the six patients, indicating that loss of GPR161 is sufficient for tumor growth, which is consistent with results of recent Gpr161 knockout studies in mice.35